examples of glp-1 receptor agonists for individualized treatment type 2 diabetes mellitus It's important to study the
Description
Anti-drug antibodies were detected in two participants
These Phase 3 RCTs currently in progress and in the pipeline should provide further clarity on the long-term safety and overall effect of once-weekly subcutaneous retatrutide
However, questions remain about their long-term safety and efficacy
T2DM, type 2 diabetes mellitus
